Atrial natriuretic peptide may inhibit motion sickness through reducing aldosterone-induced increase in endolymph volume of the inner ear

Qian-Cheng Lu, Wei Ji, Xia Li, Jian-Gang Ge, Li-Hua Xu, Zheng-Lin Jiang

Open source

DOI
10.1371/journal.pone.0359426
Published
2026-09-25
Container
PLOS One
Publisher
Public Library of Science (PLoS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0359426,
  title = {Atrial natriuretic peptide may inhibit motion sickness through reducing aldosterone-induced increase in endolymph volume of the inner ear},
  author = {Qian-Cheng Lu and Wei Ji and Xia Li and Jian-Gang Ge and Li-Hua Xu and Zheng-Lin Jiang},
  year = {2026},
  journal = {PLOS One},
  doi = {10.1371/journal.pone.0359426},
  url = {https://doi.org/10.1371/journal.pone.0359426}
}

RIS

TY  - JOUR
TI  - Atrial natriuretic peptide may inhibit motion sickness through reducing aldosterone-induced increase in endolymph volume of the inner ear
AU  - Qian-Cheng Lu
AU  - Wei Ji
AU  - Xia Li
AU  - Jian-Gang Ge
AU  - Li-Hua Xu
AU  - Zheng-Lin Jiang
PY  - 2026
JO  - PLOS One
DO  - 10.1371/journal.pone.0359426
UR  - https://doi.org/10.1371/journal.pone.0359426
ER  - 

APA

Lu, Q., Ji, W., Li, X., Ge, J., Xu, L., & Jiang, Z. (2026). Atrial natriuretic peptide may inhibit motion sickness through reducing aldosterone-induced increase in endolymph volume of the inner ear. PLOS One. https://doi.org/10.1371/journal.pone.0359426

Source records